# Catheter Ablation of Longstanding Persistent Atrial Fibrillation

Study · id `cardio:ct-nct02929836` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02929836](<https://clinicaltrials.gov/study/NCT02929836>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT02929836

Browse, organ or system: Heart  
Browse, condition area: Stroke; Heart rhythm problems  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 450 participants.

## Technical summary

Registry record NCT02929836. Randomized; single masking; primary purpose treatment. Start 2016-05 (registry gives no type); primary completion 2017-05 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 450 participants (planned count; ClinicalTrials.gov record NCT02929836, source copy `cardio:ctgov-nct02929836-2016-10-20`, retrieved 2026-10-26)
- Start date: 2016-05 (registry gives no type) (ClinicalTrials.gov record NCT02929836, source copy `cardio:ctgov-nct02929836-2016-10-20`, retrieved 2026-10-26)
- Primary completion: 2017-05 (anticipated) (ClinicalTrials.gov record NCT02929836, source copy `cardio:ctgov-nct02929836-2016-10-20`, retrieved 2026-10-26)
- Completion: 2018-10 (anticipated) (ClinicalTrials.gov record NCT02929836, source copy `cardio:ctgov-nct02929836-2016-10-20`, retrieved 2026-10-26)
- Countries: China (ClinicalTrials.gov record NCT02929836, source copy `cardio:ctgov-nct02929836-2016-10-20`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02929836-2016-10-20`, retrieved 2026-10-26)

## The registry's words

- Brief title: Catheter Ablation of Longstanding Persistent Atrial Fibrillation
- Condition: Atrial Fibrillation
- Intervention (Procedure): PVI
- Intervention (Procedure): LA linear ablation
- Intervention (Procedure): CFAE ablation
- Intervention (Procedure): linear ablation
- Intervention (Device): CARTO
- Lead sponsor: Shanghai Chest Hospital
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Arrhythmia (heart rhythm problems) (`cardio:arrhythmia`)
- Registry condition terms include this condition: Atrial fibrillation (AF) (`cardio:atrial-fibrillation`)
- Registry lists this organization as the lead sponsor: Shanghai Chest Hospital (`cardio:org-shanghai-chest-hospital`)

## Provenance

Content hash: 723e4f930b191a6e9d6ff85105b7ee94c1220d6003f442411467c9598f0f925b
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
